Small Molecules
26 June 2014
Ischemix Enrolls First Patient in Phase 2a Trial to Prevent Contrast-Induced Acute Kidney Injury26 June 2014
Evofem Announces the Completion of the Largest Phase III Contraceptive Clinical Trial to Date26 June 2014
Aurinia Pharmaceuticals Initiates Phase 2b Clinical Trial of Voclosporin to Treat Lupus Nephritis26 June 2014
EISAI SUBMITS FIRST MARKETING AUTHORIZATION APPLICATION FOR ANTICANCER AGENT LENVATINIB IN JAPAN26 June 2014
FDA Advisory Committee votes on accelerated approval for investigational medicine olaparib25 June 2014
SIGNALRX PHARMACEUTICALS DISCOVERS DUAL KINASE-EPIGENETIC INHIBITORS FOR TREATING CANCER AND OTHER DISEASES25 June 2014
Aerie Pharmaceuticals Reports RoclatanTM Phase 2b Results Achieve All Clinical EndpointsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports